Cargando…

A qualitative study of imaginary pills and open-label placebos in test anxiety

BACKGROUND: The efficacy of open-label placebos (OLPs) has been increasingly demonstrated and their use holds promise for applications compatible with basic ethical principles. Taking this concept one step further an imaginary pill (IP) intervention without the use of a physical pill was developed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Buergler, Sarah, Sezer, Dilan, Busch, Alexander, Enzmann, Marlon, Bakis, Berfin, Locher, Cosima, Bagge, Niels, Kirsch, Irving, Carvalho, Claudia, Gaab, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473493/
https://www.ncbi.nlm.nih.gov/pubmed/37656757
http://dx.doi.org/10.1371/journal.pone.0291004
_version_ 1785100285646995456
author Buergler, Sarah
Sezer, Dilan
Busch, Alexander
Enzmann, Marlon
Bakis, Berfin
Locher, Cosima
Bagge, Niels
Kirsch, Irving
Carvalho, Claudia
Gaab, Jens
author_facet Buergler, Sarah
Sezer, Dilan
Busch, Alexander
Enzmann, Marlon
Bakis, Berfin
Locher, Cosima
Bagge, Niels
Kirsch, Irving
Carvalho, Claudia
Gaab, Jens
author_sort Buergler, Sarah
collection PubMed
description BACKGROUND: The efficacy of open-label placebos (OLPs) has been increasingly demonstrated and their use holds promise for applications compatible with basic ethical principles. Taking this concept one step further an imaginary pill (IP) intervention without the use of a physical pill was developed and tested in a randomized controlled trial (RCT). To explore participants’ experiences and views, we conducted the first qualitative study in the field of IPs. METHODS: A reflexive thematic analysis (RTA) of semi-structured interviews with test anxious students (N = 20) was nested in an RCT investigating an IP and OLP intervention. In addition, open-ended questions from the RCT were evaluated (N = 114) to corroborate the RTA and pill characteristics were included to more accurately capture the IP experience. RESULTS: Four key themes were identified: (1) attitude towards the intervention, (2) applicability of the intervention, (3) experience of effects, and (4) characteristics of the imagination. The IP intervention was well-accepted, easily applicable, and various effects, pill characteristics and appearances were described. While many participants did not desire a physical pill, either due to the absence of the imagination component or aversion to pills, the approach was considered to be cognitively and time demanding, which in turn, however, encouraged the establishment of a therapeutic ritual that protected against the increase in test anxiety during the preparation phase. OLP findings were comparable, and especially the importance of a treatment rationale was stressed in both groups, counteracting an initial ambivalent attitude. The RTA findings were supported by the open-ended questions of the RCT. CONCLUSION: IPs appear to be a well-accepted and easily applicable intervention producing a variety of beneficial effects. Thus, the IP approach might serve as an imaginary based alternative to OLPs warranting further investigations on its application to harness placebo effects without a physical pill.
format Online
Article
Text
id pubmed-10473493
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-104734932023-09-02 A qualitative study of imaginary pills and open-label placebos in test anxiety Buergler, Sarah Sezer, Dilan Busch, Alexander Enzmann, Marlon Bakis, Berfin Locher, Cosima Bagge, Niels Kirsch, Irving Carvalho, Claudia Gaab, Jens PLoS One Research Article BACKGROUND: The efficacy of open-label placebos (OLPs) has been increasingly demonstrated and their use holds promise for applications compatible with basic ethical principles. Taking this concept one step further an imaginary pill (IP) intervention without the use of a physical pill was developed and tested in a randomized controlled trial (RCT). To explore participants’ experiences and views, we conducted the first qualitative study in the field of IPs. METHODS: A reflexive thematic analysis (RTA) of semi-structured interviews with test anxious students (N = 20) was nested in an RCT investigating an IP and OLP intervention. In addition, open-ended questions from the RCT were evaluated (N = 114) to corroborate the RTA and pill characteristics were included to more accurately capture the IP experience. RESULTS: Four key themes were identified: (1) attitude towards the intervention, (2) applicability of the intervention, (3) experience of effects, and (4) characteristics of the imagination. The IP intervention was well-accepted, easily applicable, and various effects, pill characteristics and appearances were described. While many participants did not desire a physical pill, either due to the absence of the imagination component or aversion to pills, the approach was considered to be cognitively and time demanding, which in turn, however, encouraged the establishment of a therapeutic ritual that protected against the increase in test anxiety during the preparation phase. OLP findings were comparable, and especially the importance of a treatment rationale was stressed in both groups, counteracting an initial ambivalent attitude. The RTA findings were supported by the open-ended questions of the RCT. CONCLUSION: IPs appear to be a well-accepted and easily applicable intervention producing a variety of beneficial effects. Thus, the IP approach might serve as an imaginary based alternative to OLPs warranting further investigations on its application to harness placebo effects without a physical pill. Public Library of Science 2023-09-01 /pmc/articles/PMC10473493/ /pubmed/37656757 http://dx.doi.org/10.1371/journal.pone.0291004 Text en © 2023 Buergler et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Buergler, Sarah
Sezer, Dilan
Busch, Alexander
Enzmann, Marlon
Bakis, Berfin
Locher, Cosima
Bagge, Niels
Kirsch, Irving
Carvalho, Claudia
Gaab, Jens
A qualitative study of imaginary pills and open-label placebos in test anxiety
title A qualitative study of imaginary pills and open-label placebos in test anxiety
title_full A qualitative study of imaginary pills and open-label placebos in test anxiety
title_fullStr A qualitative study of imaginary pills and open-label placebos in test anxiety
title_full_unstemmed A qualitative study of imaginary pills and open-label placebos in test anxiety
title_short A qualitative study of imaginary pills and open-label placebos in test anxiety
title_sort qualitative study of imaginary pills and open-label placebos in test anxiety
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473493/
https://www.ncbi.nlm.nih.gov/pubmed/37656757
http://dx.doi.org/10.1371/journal.pone.0291004
work_keys_str_mv AT buerglersarah aqualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT sezerdilan aqualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT buschalexander aqualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT enzmannmarlon aqualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT bakisberfin aqualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT lochercosima aqualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT baggeniels aqualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT kirschirving aqualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT carvalhoclaudia aqualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT gaabjens aqualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT buerglersarah qualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT sezerdilan qualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT buschalexander qualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT enzmannmarlon qualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT bakisberfin qualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT lochercosima qualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT baggeniels qualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT kirschirving qualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT carvalhoclaudia qualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety
AT gaabjens qualitativestudyofimaginarypillsandopenlabelplacebosintestanxiety